Last reviewed · How we verify

NCT05139862: NCP

Neurocardiac Predictors of Treatment Response to RTMS in Depression

Not yet recruiting NA Last updated 24 December 2024
What this trial tests

NA trial testing Repetitive Transcranial Magnetic Stimulation in Depression in 110 participants. Not yet recruiting.

Timeline
1 May 2025
Primary endpoint
1 December 2028
1 December 2028

Quick facts

Lead sponsorUniversity of British Columbia
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment110
Start date1 May 2025
Primary completion1 December 2028
Estimated completion1 December 2028
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

University of British Columbia

Who can join

Adults 19 to 65, any sex, with Depression or Treatment Resistant Depression. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Heartbeat is controlled by the brain and is regular but flexible to change in response to environmental and internal stimuli. This feature is known as heart rate variability (HRV). Major depressive disorder (MDD) has been associated with diminished HRV and this is a reflection of abnormal brain function caused by MDD. Repetitive transcranial magnetic stimulation (rTMS) is a treatment that stimulates specific areas of the brain. The goal of this study is to test the hypothesis that rTMS induces changes in connectivity between the area of the brain stimulated with rTMS and deeper areas in the brain associated to heart rate regulation. 110 patients with TRD will be recruited and will undergo a concurrent TMS-fMRI session before receiving a course of iTBS to the L-DLPFC for 30 sessions at 120% rMT.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Repetitive Transcranial Magnetic Stimulation

Trials testing the same drug.

Other recruiting trials for Depression

Currently open trials in the same condition.

Other University of British Columbia trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05139862.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing